IS5805A - Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum - Google Patents

Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum

Info

Publication number
IS5805A
IS5805A IS5805A IS5805A IS5805A IS 5805 A IS5805 A IS 5805A IS 5805 A IS5805 A IS 5805A IS 5805 A IS5805 A IS 5805A IS 5805 A IS5805 A IS 5805A
Authority
IS
Iceland
Prior art keywords
prolongation
compositions
materials
methods
nerve
Prior art date
Application number
IS5805A
Other languages
English (en)
Icelandic (is)
Inventor
Katho Susumu
Kawakami Hiroshi
Tada Hiroki
Angelica Linton Maria
Kalish Vincent
Howard Tatlock John
Ernesto Villafranca Jesus
Original Assignee
Agouron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of IS5805A publication Critical patent/IS5805A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
IS5805A 1998-07-17 2001-01-12 Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum IS5805A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9329998P 1998-07-17 1998-07-17
US13288499P 1999-05-06 1999-05-06
PCT/US1999/015965 WO2000004020A1 (en) 1998-07-17 1999-07-15 Compounds, compositions, and methods for stimulating neuronal growth and elongation

Publications (1)

Publication Number Publication Date
IS5805A true IS5805A (is) 2001-01-12

Family

ID=26787372

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5805A IS5805A (is) 1998-07-17 2001-01-12 Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum

Country Status (35)

Country Link
US (1) US6630472B1 (https=)
EP (1) EP1098897B1 (https=)
JP (1) JP2002520413A (https=)
KR (1) KR20010071920A (https=)
CN (1) CN1318067A (https=)
AP (1) AP2001002052A0 (https=)
AT (1) ATE268772T1 (https=)
AU (1) AU756912B2 (https=)
BG (1) BG105268A (https=)
BR (1) BR9912423A (https=)
CA (1) CA2337377A1 (https=)
DE (1) DE69917907T2 (https=)
DK (1) DK1098897T3 (https=)
EA (1) EA200100149A1 (https=)
EE (1) EE200100032A (https=)
ES (1) ES2226409T3 (https=)
GE (1) GEP20043368B (https=)
HR (1) HRP20010118A2 (https=)
HU (1) HUP0200637A3 (https=)
ID (1) ID27428A (https=)
IL (1) IL140676A0 (https=)
IS (1) IS5805A (https=)
LT (1) LT4850B (https=)
LV (1) LV12665B (https=)
NO (1) NO20010191L (https=)
NZ (1) NZ509211A (https=)
OA (1) OA11581A (https=)
PL (1) PL345598A1 (https=)
PT (1) PT1098897E (https=)
SI (1) SI20638A (https=)
SK (1) SK462001A3 (https=)
TR (1) TR200100122T2 (https=)
WO (1) WO2000004020A1 (https=)
YU (1) YU2901A (https=)
ZA (1) ZA200100320B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818643B1 (en) * 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
CA2446795A1 (en) * 2001-05-10 2002-11-14 Agouron Pharmaceuticals, Inc. Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
EP2899192A1 (en) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
EP3097103B1 (en) * 2014-01-24 2017-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5109112A (en) 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
US5196352A (en) 1989-01-19 1993-03-23 Merck & Co., Inc. New FK-506 cytosolic binding protein
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
CA2068062A1 (en) 1991-05-07 1992-11-08 Stephen A. Parent Yeast mutants
US5362629A (en) 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
DE4219973A1 (de) 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5318895A (en) 1992-10-05 1994-06-07 Merck & Co., Inc. Aspergillus niger mutants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5457182A (en) 1994-02-15 1995-10-10 Merck & Co., Inc. FK-506 cytosolic binding protein, FKBP12.6
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
AR010744A1 (es) 1996-12-09 2000-07-12 Guildford Pharmaceuticals Inc Inhibidores polipropilos de ciclofilina
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones

Also Published As

Publication number Publication date
LV12665A (en) 2001-05-20
LV12665B (lv) 2001-11-20
NZ509211A (en) 2002-10-25
SK462001A3 (en) 2002-02-05
SI20638A (sl) 2002-02-28
JP2002520413A (ja) 2002-07-09
CN1318067A (zh) 2001-10-17
ATE268772T1 (de) 2004-06-15
US6630472B1 (en) 2003-10-07
EP1098897B1 (en) 2004-06-09
TR200100122T2 (tr) 2001-08-21
WO2000004020A1 (en) 2000-01-27
HUP0200637A2 (en) 2002-08-28
IL140676A0 (en) 2002-02-10
LT4850B (lt) 2001-10-25
YU2901A (sh) 2004-05-12
KR20010071920A (ko) 2001-07-31
ZA200100320B (en) 2002-07-11
ES2226409T3 (es) 2005-03-16
CA2337377A1 (en) 2000-01-27
GEP20043368B (en) 2004-04-13
BR9912423A (pt) 2001-06-05
DE69917907T2 (de) 2005-06-30
LT2001012A (en) 2001-07-25
HRP20010118A2 (en) 2002-02-28
PT1098897E (pt) 2004-10-29
PL345598A1 (en) 2001-12-17
EP1098897A1 (en) 2001-05-16
NO20010191D0 (no) 2001-01-12
EE200100032A (et) 2002-06-17
DK1098897T3 (da) 2004-10-18
AU4996399A (en) 2000-02-07
EA200100149A1 (ru) 2001-08-27
ID27428A (id) 2001-04-05
AU756912B2 (en) 2003-01-23
OA11581A (en) 2004-07-23
DE69917907D1 (de) 2004-07-15
HUP0200637A3 (en) 2003-05-28
AP2001002052A0 (en) 2001-03-31
BG105268A (en) 2001-11-30
NO20010191L (no) 2001-03-16

Similar Documents

Publication Publication Date Title
IS6182A (is) A-beta peptíði og ferli til að búa þær til
IS5097A (is) Fenófíbrat lyfjasamsetning með háa lífeðlisfræðilega upptöku og aðferð til framleiðslu hennar
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
ATE413386T1 (de) Ppar-gamma modulatoren
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
TWI315988B (en) Chemically modified novel erythropoietin stimulating protein compositions and methods
HUP0500634A3 (en) Materials and methods to promote repair of nerve tissue
DK1423102T3 (da) Plaster til behandling af neglevæksts dysfunktioner og lidelser
IL143488A0 (en) Cancer treatment composition and method using natural plant essential oils
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DE69728057D1 (de) Iontophoretische auslösbare lieferungsvorrichtung zur verminderung von elektrischen empfindungen
NO20005692D0 (no) Forbedringer i og vedrörende bygningselementer, og fremgangsmåter vedrörende samme
ATE306481T1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
AU2003216482A8 (en) Msras as modifiers of the p53 pathway and methods of use
NO20000602L (no) Krembasert matsammensetning og fremgangsmåte for fremstilling derav
ID25699A (id) Komposisi untuk merangsang pertumbuhan tanaman dan untuk memperbaiki pengawetan tanaman dan metoda untuk mempersiapkannya
IS2344B (is) Efni til að bæta verkfræðilega eiginleika jarðvegs
DK1472221T3 (da) Substituerede indoler, fremgangsmåde til fremstilling deraf og deres anvendelse til bekæmpelse af smerter
IS6574A (is) Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IS6368A (is) Aðferð við að skera í sundur afurðir og tæki til að beita aðferðinni
IS5805A (is) Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum
DK1307237T3 (da) Perfluoralkylholdige komplekser med polære grupper, fremgangsmåde til fremstilling og anvendelse heraf
IS4590A (is) Vaxtarbeinar fyrir taugaþræði í miðtaugakerfi, ogsamsetningar, frumur og aðferðir sem innihalda ognýta þá
AU6346699A (en) Method for stimulating the natural defences of plants
EA199900458A3 (ru) Способ и промежуточные продукты для получения пиридин-2,3-дикарбоксилатов